Methanone, [6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]-,hydrochloride (1:1)

CAS: 82640-04-8

Ref. AN-AG003AAG

Produktinformation

• Name: Methanone, [6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]-,hydrochloride (1:1)
• Synonyme: [u'Evista', u'Keoxifene', u'Keoxifene Hydrochloride', u'LY 139481', u'LY 156758', u'LY-139481', u'LY-156758', u'LY139481', u'LY156758', u'Raloxifene', u'Raloxifene HCl', u'Raloxifene Hydrochloride', u'RALOXIFENE HYDROCHLORIDE', u'82640-04-8', u'Raloxifene Hcl', u'Evista', u'Keoxifene hydrochloride', u'Keoxifene', u'(6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thiophen-3-yl)(4-(2-(piperidin-1-yl)ethoxy)phenyl)methanone hydrochloride', u'LY 156758', u'Raloxifene (hydrochloride)', u'UNII-4F86W47BR6', u'CHEBI:50740', u'Evista (Raloxifene Hydrochloride)', u'4F86W47BR6', u'Optruma', u'MFCD01938233', u'LY-156758', u'6-Hydroxy-2-(p-hydroxyphenyl)benzo(b)thien-3-yl-p-(2-piperidinoethoxy)phenyl ketone, hydrochloride', u'C28H28ClNO4S', u'DSSTox_CID_14181', u'DSSTox_RID_79119', u'DSSTox_GSID_34181', u'[6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone hydrochloride', u'2-(4-hydroxyphenyl)-3-({4-[2-(piperidin-1-yl)ethoxy]phenyl}carbonyl)-1-benzothiophen-6-ol hydrochloride', u'2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol hydrochloride', u'Methanone, (6-hydroxy-2-(4-hydroxyphenyl)benzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)-, hydrochloride', u'SMR000058508', u'NCGC00015889-05', u'CAS-82640-04-8', u'Loxifen', u'SR-01000076102', u'Keoxifene HCl', u'CDT-Raloxifene', u'Raloxifene hydrochloride [USAN]', u'[6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone;hydrochloride', u'Evista (TN)', u'Prestwick_1035', u'Raloxifene hydrochloride [USAN:USP]', u'LY156758', u'Methanone, hydrochloride', u'LY156758 hydrochloride', u'AC1L1HY9', u'AC1Q3F5K', u'C28H27NO4S.HCl', u'Study Drug, raloxifene HCI', u'CHEMBL1116', u'SCHEMBL19077', u'MLS000859902', u'MLS001332533', u'MLS001332534', u'MLS002222293', u'Raloxifene hydrochloride, solid', u'Evista, Raloxifene hydrochloride', u'DTXSID1034181', u'LY156758 (Keoxifene) HCl', u'CTK7J9865', u'KS-00000JPS', u'LY-139481 HCl', u'BKXVVCILCIUCLG-UHFFFAOYSA-N', u'HMS1570N05', u'Pharmakon1600-01505622', u'BCP05713', u'Raloxifene hydrochloride (JAN/USP)', u'Tox21_110255', u'Tox21_302369', u'Tox21_501051', u'ANW-54600', u'HY-13738A', u'NSC706725', u'NSC759285', u's1227', u'AKOS008131940', u'Tox21_110255_1', u'AC-8390', u'AN-8061', u'CCG-213497', u'CS-1775', u'DS-2162', u'KS-1102', u'LP01051', u'MCULE-7336063262', u'NC00665', u'NSC-706725', u'NSC-759285', u'RP17875', u'VA11647', u'NCGC00015889-03', u'NCGC00015889-11', u'NCGC00092353-01', u'NCGC00092353-03', u'NCGC00094334-01', u'NCGC00094334-02', u'NCGC00255153-01', u'NCGC00261736-01', u'4CA-1076', u'AK-54611', u'BC209548', u'CPD000058508', u'LS-91271', u'SAM002548975', u'SC-20043', u'AB0020647', u'TC-063566', u'EU-0101051', u'FT-0630912', u'R0109', u'ST24020666', u'SW197106-5', u'V1611', u'EN300-52517', u'D02217', u'J90021', u'M-8965', u'R 1402', u'68523-EP2270008A1', u'68523-EP2292617A1', u'68523-EP2298768A1', u'68523-EP2308855A1', u'640R048', u'I06-1061', u'I14-1208', u'Q-201656', u'SR-01000076102-2', u'SR-01000076102-9', u'Raloxifene hydrochloride, European Pharmacopoeia (EP) Reference Standard', u'Raloxifene Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material'], 2-(4-Hydroxyphenyl)-3-[4-[2-(piperidin-1-yl)ethoxy]benzoyl]-1-benzothiophen-6-ol hydrochloride, 6-Hydroxy-2-(p-hydroxyphenyl)benzo(b)thien-3-yl-p-(2-piperidinoethoxy)phenyl ketone, hydrochloride, Bonebay, Bontact, Evista, Fiona, Keoxifene hydrochloride, Ly 156758, Methanone, (6-hydroxy-2-(4-hydroxyphenyl)benzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)-, hydrochloride, Methanone, [6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]-, hydrochloride (1:1), Optruma, Ralista, Ralofen, Raloxifene HCl, Raloxifene hydrochloride [USAN], Reloxafine, Unii-4F86W47Br6, [6-Hydroxy-2-(4-Hydroxyphenyl)-1-Benzothiophen-3-Yl]{4-[2-(Piperidin-1-Yl)Ethoxy]Phenyl}Methanone Hydrochloride (1:1), [6-Hydroxy-2-(4-Hydroxyphenyl)-2,3-Dihydro-1-Benzothiophen-3-Yl][4-(2-Piperidin-1-Ylethoxy)Phenyl]Methanone
• CAS: 82640-04-8
• Marke: Indagoo

Chemische Eigenschaften

• Molekulargewicht: 510.0442
• Formel: C₂₈H₂₈ClNO₄S
• Reinheit: 98%
• Farbe/Form: Solid
• InChl: InChI=1S/C28H27NO4S.ClH/c30-21-8-4-20(5-9-21)28-26(24-13-10-22(31)18-25(24)34-28)27(32)19-6-11-23(12-7-19)33-17-16-29-14-2-1-3-15-29;/h4-13,18,30-31H,1-3,14-17H2;1H
• InChI Key: BKXVVCILCIUCLG-UHFFFAOYSA-N